US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist

3.500
0.0000.00%

Close Nov 7 16:00 ET

2.99MMarket Cap0.00P/E (TTM)

Scinai Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

284K

Operating revenue

--284K

--0

Cost of revenue

Gross profit

Operating expense

-28.21%1.86M

-39.49%1.93M

-12.25%9.71M

-39.68%1.82M

-2.73%2.1M

-20.47%2.6M

21.84%3.19M

1.83%11.06M

-12.26%3.02M

-15.40%2.16M

Selling and administrative expenses

-54.51%519K

-59.36%484K

-14.94%4.51M

-24.12%1.21M

0.10%968K

-11.48%1.14M

-17.98%1.19M

-30.54%5.3M

-30.38%1.59M

-49.79%967K

Research and development costs

-16.09%1.22M

-21.40%1.57M

-9.63%5.21M

-56.28%627K

-5.03%1.13M

-26.34%1.45M

71.54%2M

77.44%5.77M

22.00%1.43M

89.96%1.19M

Other operating expenses

----

---124K

---9K

----

Operating profit

21.89%-2.03M

39.49%-1.93M

12.25%-9.71M

39.68%-1.82M

2.73%-2.1M

20.47%-2.6M

-21.84%-3.19M

-1.83%-11.06M

12.26%-3.02M

15.40%-2.16M

Net non-operating interest income expense

74.72%-295K

29.79%-231K

-96.20%115K

16.89%-3.6M

-24.93%5.21M

-516.79%-1.17M

-335.00%-329K

-3.60%3.03M

-190.16%-4.33M

2,821.55%6.94M

Non-operating interest income

----

-95.97%123K

----

-3.20%3.05M

----

Non-operating interest expense

--295K

-29.79%231K

----

--329K

----

Total other finance cost

----

-61.90%8K

-49.58%3.72M

24.93%-5.21M

516.79%1.17M

----

133.33%21K

--7.38M

---6.94M

Other net income (expense)

38.30%3.09M

558.93%2.24M

Gain on sale of security

----

38.30%3.09M

----

558.93%2.24M

----

Income before tax

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

270.08%4.78M

Income tax

Net income

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

270.08%4.78M

Net income continuous Operations

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

270.08%4.78M

Minority interest income

Net income attributable to the parent company

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

270.08%4.78M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

270.08%4.78M

Basic earnings per share

66.67%-4

60.00%-16

77.78%-8

-80.00%8

25.00%-12

0.00%-12

50.00%-40

-101.24%-36

261.00%40

Diluted earnings per share

66.67%-4

60.00%-16

77.78%-8

-80.00%8

25.00%-12

0.00%-12

50.00%-40

-101.24%-36

261.00%40

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	284K	0	0	0	0	0	0	0	0	0
Operating revenue	--284K	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-28.21%1.86M	-39.49%1.93M	-12.25%9.71M	-39.68%1.82M	-2.73%2.1M	-20.47%2.6M	21.84%3.19M	1.83%11.06M	-12.26%3.02M	-15.40%2.16M
Selling and administrative expenses	-54.51%519K	-59.36%484K	-14.94%4.51M	-24.12%1.21M	0.10%968K	-11.48%1.14M	-17.98%1.19M	-30.54%5.3M	-30.38%1.59M	-49.79%967K
Research and development costs	-16.09%1.22M	-21.40%1.57M	-9.63%5.21M	-56.28%627K	-5.03%1.13M	-26.34%1.45M	71.54%2M	77.44%5.77M	22.00%1.43M	89.96%1.19M
Other operating expenses	----	---124K	---9K	----	----	----	----	----	----	----
Operating profit	21.89%-2.03M	39.49%-1.93M	12.25%-9.71M	39.68%-1.82M	2.73%-2.1M	20.47%-2.6M	-21.84%-3.19M	-1.83%-11.06M	12.26%-3.02M	15.40%-2.16M
Net non-operating interest income expense	74.72%-295K	29.79%-231K	-96.20%115K	16.89%-3.6M	-24.93%5.21M	-516.79%-1.17M	-335.00%-329K	-3.60%3.03M	-190.16%-4.33M	2,821.55%6.94M
Non-operating interest income	----	----	-95.97%123K	----	----	----	----	-3.20%3.05M	----	----
Non-operating interest expense	--295K	-29.79%231K	----	----	----	----	--329K	----	----	----
Total other finance cost	----	----	-61.90%8K	-49.58%3.72M	24.93%-5.21M	516.79%1.17M	----	133.33%21K	--7.38M	---6.94M
Other net income (expense)			38.30%3.09M					558.93%2.24M
Gain on sale of security	----	----	38.30%3.09M	----	----	----	----	558.93%2.24M	----	----
Income before tax	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M	270.08%4.78M
Income tax
Net income	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M	270.08%4.78M
Net income continuous Operations	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M	270.08%4.78M
Minority interest income
Net income attributable to the parent company	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M	270.08%4.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M	270.08%4.78M
Basic earnings per share	66.67%-4	66.67%-4	60.00%-16	77.78%-8	-80.00%8	25.00%-12	0.00%-12	50.00%-40	-101.24%-36	261.00%40
Diluted earnings per share	66.67%-4	66.67%-4	60.00%-16	77.78%-8	-80.00%8	25.00%-12	0.00%-12	50.00%-40	-101.24%-36	261.00%40
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data